Anodic voltammetric behavior and determination of rosiglitazone in pharmaceutical dosage forms and biological fluids on solid electrode.
The anodic voltammetric behavior and electroanalytical determination of rosiglitazone was studied using cyclic, linear sweep, differential pulse and square wave voltammetric techniques on glassy carbon electrode. The oxidation of rosiglitazone was irreversible and exhibited diffusion controlled process depending on pH. Different parameters were tested to optimize the conditions for the determination of the oxidation mechanism of rosiglitazone. The dependence of current intensities and potentials on pH, concentration, scan rate, nature of the buffer was also investigated. According to the linear relationship between the peak current and the concentration, differential pulse and square wave voltammetric methods for rosiglitazone assay in pharmaceutical dosage forms and biological fluids were developed. A linear response was obtained within the range of 1x10-6M - 6x10-5M in 0.1 M H2SO4 and acetate buffer at pH 5.70 for both voltammetric methods in human serum samples. The practical analytical value of the method is demonstrated by quantitative determination of rosiglitazon in pharmaceutical formulation and human serum, without the need for separation or complex sample preparation, since there was no interference from the excipients and endogenous substances. The methods were fully validated and successfully applied to the high throughput determination of the drug in tablets and human serum with good recoveries.
Dogan-Topal
Burcu
B
Department of Analytical Chemistry, Ankara University, Tandogan, Turkey.
Tuncel
Secil
S
Ozkan
Sibel A
SA
D002244:Carbon / Q000737:chemistry; D004304:Dosage Forms; D004563:Electrochemistry; D004566:Electrodes; D057166:High-Throughput Screening Assays; D006801:Humans; D006863:Hydrogen-Ion Concentration; D004364:Pharmaceutical Preparations / Q000032:analysis*; D000077154:Rosiglitazone; D012680:Sensitivity and Specificity; D013499:Surface Properties; D045162:Thiazolidinediones / Q000032:analysis*
D004304:Dosage Forms; D004364:Pharmaceutical Preparations; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D002244:Carbon